Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety of therapy with nab-paclitaxel
and CsA and if the addition of Cyclosporine A (CsA) to nab-paclitaxel helps stop cancer cells
as well as or better than nab-paclitaxel alone.